Zobrazeno 1 - 4
of 4
pro vyhledávání: '"João Paulo G. Camporez"'
Autor:
João Paulo G. Camporez, Shoichi Kanda, Max C. Petersen, François R. Jornayvaz, Varman T. Samuel, Sanjay Bhanot, Kitt Falk Petersen, Michael J. Jurczak, Gerald I. Shulman
Publikováno v:
Journal of Lipid Research, Vol 56, Iss 3, Pp 526-536 (2015)
ApoA5 has a critical role in the regulation of plasma TG concentrations. In order to determine whether ApoA5 also impacts ectopic lipid deposition in liver and skeletal muscle, as well as tissue insulin sensitivity, we treated mice with an antisense
Externí odkaz:
https://doaj.org/article/378e07a47d21452e8c3cbb1b31db8d9b
Autor:
Domenick J. Falcone, Joanne Bruno, Muheeb Beg, Barbara B. Kahn, João Paulo G Camporez, Melanie S Buckman, Christopher Torsitano, L Amanda Sadacca, Domenico Accili, Olivier Elemento, Gerald I. Shulman, Belén Picatoste, Timothy E. McGraw, Akanksha Verma, Gabriela Virginia Moreira, Rajesh T. Patel, Reema P. Vazirani, Kotryna Simonyte
Publikováno v:
Diabetes
Insulin controls glucose uptake into adipose and muscle cells by regulating the amount of GLUT4 in the plasma membrane. The effect of insulin is to promote the translocation of intracellular GLUT4 to the plasma membrane. The small Rab GTPase, Rab10,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a075da6d9553b7516e4372e7189b46d8
https://doi.org/10.2337/db15-1128
https://doi.org/10.2337/db15-1128
Autor:
Kevin C. Corbit, João Paulo G. Camporez, Jennifer L. Tran, Camella G. Wilson, Dylan Lowe, Sarah Nordstrom, Kirthana Ganeshan, Rachel J. Perry, Gerald I. Shulman, Michael J. Jurczak, Ethan J. Weiss
For nearly 100 years, Growth Hormone (GH) has been known to impact insulin sensitivity and risk of diabetes. However, the tissue governing the effects of GH signaling on insulin and glucose homeostasis remains unknown. Excess GH reduces fat mass and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52d248729dada2dd44ec755e173d9ffa
Autor:
Mohamed Asrih, Varman T Samuel, François R Jornayvaz, Dongyan Zhang, Michael J. Jurczak, Mario Kahn, João Paulo G Camporez
Publikováno v:
Journal of Endocrinology, Vol. 226, No 3 (2015) pp. 207-217
Fibroblast growth factor 21 (FGF21) is an important regulator of hepatic glucose and lipid metabolism and represents a potential pharmacological agent for the treatment of type 2 diabetes and obesity. Mice fed a ketogenic diet (KD) develop hepatic in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b026d6de8e5df1d2ebf5e2538e0841e
https://pubmed.ncbi.nlm.nih.gov/26203166
https://pubmed.ncbi.nlm.nih.gov/26203166